Etoricoxib-induced toxic epidermal necrolysis: A fatal case report

被引：10

作者：

Roy, Sukalyan Saha ^{[1
]}

Mukherjee, Shatavisa ^{[1
]}

Era, Nikhil ^{[1
]}

Mukherjee, Mala ^{[2
]}

机构：

[1] Calcutta Sch Trop Med, Dept Clin & Expt Pharmacol, Kolkata 700073, W Bengal, India

[2] MGM Med Coll, Dept Pathol, Kishanganj, Bihar, India

来源：

INDIAN JOURNAL OF PHARMACOLOGY | 2018年 / 50卷 / 03期

关键词：

Adverse effects; algorithm of drug causality for epidermal necrolysis; etoricoxib; SCORTEN score; toxic epidermal necrolysis; STEVENS-JOHNSON SYNDROME; ADVERSE DRUG-REACTIONS;

D O I：

10.4103/ijp.IJP_39_17

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Cyclooxygenase inhibitors were developed in the quest of enhanced analgesic efficacy devoid of gastric side effects. High usage of etoricoxib by prescription as well as self-administered routes has led to increasing reports of side effects and adverse reactions including dermatologic reactions in 0.1%-0.3% of cases. The present report enumerates a case of toxic epidermal necrolysis induced by etoricoxib.

引用

页码：139 / 142

页数：4

共 12 条

[1] SCORTEN: A severity-of-illness score for toxic epidermal necrolysis
Bastuji-Garin, S
Fouchard, N
Bertocchi, M
Roujeau, JC
Revuz, J
Wolkenstein, P
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (02) : 149 - 153
[2] Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies
Bouvy, Jacoline C.
De Bruin, Marie L.
Koopmanschap, Marc A.
[J]. DRUG SAFETY, 2015, 38 (05) : 437 - 453
[3] Fritz P.O., 2003, FITZPATRICKS DERMATO, P543
[4] Gurung A, 2016, INT J BASIC CLIN PHA, V5, P531
[5] A case report on toxic epidermal necrolysis with etoricoxib
Kameshwari, J. S.
Devde, Raju
[J]. INDIAN JOURNAL OF PHARMACOLOGY, 2015, 47 (02) : 221 - 223
[6] Etoricoxib-induced toxic epidermal necrolysis: Successful treatment with infliximab
Kreft, Burkhard
Wohlrab, Johannes
Bramsiepe, Isa
Eismann, Regina
Winkler, Matthias
Marsch, Christian
[J]. JOURNAL OF DERMATOLOGY, 2010, 37 (10) : 904 - 906
[7] Mockenhaupt M, 2011, EXPERT REV CLIN IMMU, V7, P803, DOI [10.1586/eci.11.66, 10.1586/ECI.11.66]
[8] A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS
NARANJO, CA
BUSTO, U
SELLERS, EM
SANDOR, P
RUIZ, I
ROBERTS, EA
JANECEK, E
DOMECQ, C
GREENBLATT, DJ
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) : 239 - 245
[9] Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap Secondary to Interaction Between Methotrexate and Etoricoxib: A Case Report
Rachana, P. R.
Anuradha, H. V.
Mounika, Reddy
[J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (07) : FD01 - FD03
[10] ALDEN, an Algorithm for Assessment of Drug Causality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case-Control Analysis
Sassolas, B.
Haddad, C.
Mockenhaupt, M.
Dunant, A.
Liss, Y.
Bork, K.
Haustein, U. F.
Vieluf, D.
Roujeau, J. C.
Le Louet, H.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (01) : 60 - 68

← 1 2 →